Cardiomyocyte-specific knockout of ADAM17 alleviates doxorubicin-induced cardiomyopathy via inhibiting TNFα–TRAF3–TAK1–MAPK axis

Abstract The pathogenesis of doxorubicin-induced cardiomyopathy remains unclear. This study was carried out to test our hypothesis that ADAM17 aggravates cardiomyocyte apoptosis induced by doxorubicin and inhibition of ADAM17 may ameliorate doxorubicin-induced cardiomyopathy. C57BL/6J mice were intr...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Lin Xie, Fei Xue, Cheng Cheng, Wenhai Sui, Jie Zhang, Linlin Meng, Yue Lu, Wenjing Xiong, Peili Bu, Feng Xu, Xiao Yu, Bo Xi, Lin Zhong, Jianmin Yang, Cheng Zhang, Yun Zhang
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Nature Publishing Group 2024-10-01
Serie:	Signal Transduction and Targeted Therapy
Länkar:	https://doi.org/10.1038/s41392-024-01977-z
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!